Algo version: 0.98b
Nahdi Medical Company is listed at the SAU Exchange
Nahdi Medical Company [4164.SR]
SAU Sector: Healthcare Industry:Pharmaceutical Retailers

Is Nahdi Medical Company stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Nahdi Medical Company pays dividends. Last time was Sunday 25th of August 2024 where the investors holding the stock on Sunday 11th of August 2024 were paid SAR2.5 per share. Over the last 5 times between 2022 and 2024, Nahdi Medical Company has paid SAR13.31 with an average of SAR2.66 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Nahdi Medical Company 10 years ago, but if you had invested on Tuesday 22nd of March 2022 when the price was SAR150.00, you would have made a loss of SAR-20.00 per share or -13.33%

Yes, the average daily trading liquidity for Nahdi Medical Company is SAR207 451 thousand. You should therefore be able to get in and out of your positions relatively fast.

Nahdi Medical Company has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.02, the company's ability to pay off the debt is good. Nahdi Medical Company has a good net profit margin of 9.94% and should have high tolerances against inflation.

We have calculated the inflation risk for Nahdi Medical Company to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.